Paige, a global leader in clinical AI applications in pathology, today announced it received CE-IVD and UKCA marks for HER2Complete, an artificial intelligence (AI) software designed to identify patients with breast cancer whose tumors have expressions of human epidermal growth factor receptor 2 (HER2) protein.
Digital technologies can help improve pathology workflows by automating the review of immunohistochemistry (IHC) slides, which are the cornerstone of diagnostic pathology. However, the inability to simultaneously view multiple digital slides contributes to delays in diagnosis and hinders the widespread clinical adoption of digital pathology.
AFTER TWO YEARS OF COMPLETE REDESIGN, TRIBUN HEALTH IS PROUD TO ANNOUNCE THE RELEASE OF TELESLIDE PATHO 5.
Researchers now expect to gain valuable new insights into highly aggressive prostate cancer by combining Artificial Intelligence (AI)-powered diagnostic imaging with three-dimensional (3D) tissue imaging.
PARIS, May 25, 2022 (Newswire.com) Tribun Health today announced the appointment of Ludovic d'Apréa as Chief Customer Officer (CCO) of the Company, in charge of global sales and operations, including projects implementation and customer care. Ludovic has a proven track record as a global leader of motivating and developing strong teams while driving complex change, putting a strong set [...]
Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by Janssen, to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds.
In a recent study, researchers from the Boston University School of Medicine developed a graph-based vision transformer to predict disease grades by fusing graph-based representations of WSIs. By combining the computational efficiency of transformer architectures and clinical information from graph representations of pathology WSIs, the graph transformer can improve the accuracy of WSI classification.
Regulatory milestone to accelerate company’s international growth amid expanding presence in Europe PHILADELPHIA - June 8, 2022 - Proscia®, a leader in digital and computational pathology solutions, today announced that its Concentriq® Dx platform has been certified under the new In Vitro Diagnostic Regulation (IVDR) for use in primary diagnosis. This certification will enable the company’s continued growth in the [...]
Researchers from the Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, evaluated how different digital pathology operations influenced digital storage costs, scanner dropouts, and throughput of whole slide imaging.
Proscia®, a leader in digital and computational pathology solutions, has introduced an automated quality control application that leverages artificial intelligence to improve quality and efficiency in data-driven drug development. In launching automated quality control, Proscia is delivering on digital pathology’s first suite of process automation solutions, streamlining manual, repetitive tasks with AI. The company has also released a new version of its Concentriq® for Research platform to further unify global pathology operations and centralize data across the connected enterprise.
